ArticleBreast cancer research and treatment2022

Endocrine therapy initiation among women with stage I-III invasive, hormone receptor-positive breast cancer from 2001-2016.

Erin J Aiello Bowles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.